Correlation Between Cardio Diagnostics and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Cns Pharmaceuticals, you can compare the effects of market volatilities on Cardio Diagnostics and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Cns Pharmaceuticals.
Diversification Opportunities for Cardio Diagnostics and Cns Pharmaceuticals
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cardio and Cns is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Cns Pharmaceuticals
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 1.4 times more return on investment than Cns Pharmaceuticals. However, Cardio Diagnostics is 1.4 times more volatile than Cns Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Cns Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 22.00 in Cardio Diagnostics Holdings on August 31, 2024 and sell it today you would earn a total of 8.00 from holding Cardio Diagnostics Holdings or generate 36.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardio Diagnostics Holdings vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Cardio Diagnostics |
| Cns Pharmaceuticals |
Cardio Diagnostics and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardio Diagnostics and Cns Pharmaceuticals
The main advantage of trading using opposite Cardio Diagnostics and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |